ACE and Hypertension: Here we demonstrate that in the Gata1low murine model of spontaneous myelofibrosis a 2‐month administration of captopril, an ACE inhibitor commonly used for the treatment of systemic hypertension, decreased bone marrow megakaryocytic hyperplasia and marrow fibrosis.